Steris (NYS: STE) reported earnings on Feb. 8. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q3), Steris met expectations on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded and GAAP earnings per share increased significantly.
Gross margins contracted, operating margins contracted, and net margins increased.
Steris booked revenue of $355.2 million. The six analysts polled by S&P Capital IQ expected revenue of $360.5 million on the same basis. GAAP reported sales were 8.2% higher than the prior-year quarter's $328.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $0.59. The seven earnings estimates compiled by S&P Capital IQ forecast $0.60 per share on the same basis. GAAP EPS of $0.58 for Q3 were 61% higher than the prior-year quarter's $0.36 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 38.9%, 290 basis points worse than the prior-year quarter. Operating margin was 15.5%, 150 basis points worse than the prior-year quarter. Net margin was 9.5%, 290 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $373.3 million. On the bottom line, the average EPS estimate is $0.61.
Next year's average estimate for revenue is $1.39 billion. The average EPS estimate is $2.19.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 89 members out of 107 rating the stock outperform, and 18 members rating it underperform. Among 29 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 26 give Steris a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Steris is outperform, with an average price target of $38.
Can your retirement portfolio provide you with enough income to last? You'll need more than Steris. Learn about crafting a smarter retirement plan in "The Shocking Can't-Miss Truth About Your Retirement." Click here for instant access to this free report.
Add Steris to My Watchlist.
At the time thisarticle was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.